title: Is it safe to combine PPAR agonists? A lesson from muraglitazar.
authors.forename: Tomas
authors.initials: T
authors.lastname: Stulc
authors.forename: Richard
authors.initials: R
authors.lastname: Ceska
mesh_terms: D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology; D004347:Drug Interactions; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008954:Models, Biological; D010080:Oxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D047493:PPAR alpha / Q000819:agonists*; D047495:PPAR gamma / Q000819:agonists*
chemical_list: D010080:Oxazoles; D047493:PPAR alpha; D047495:PPAR gamma; D005998:Glycine; C500085:muraglitazar